|Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies|
A Antoniou, PDP Pharoah, S Narod, HA Risch, JE Eyfjord, JL Hopper, ...
American journal of human genetics 72 (5), 1117, 2003
|Genome-wide association study identifies novel breast cancer susceptibility loci|
DF Easton, KA Pooley, AM Dunning, PDP Pharoah, D Thompson, ...
Nature 447 (7148), 1087-1093, 2007
|Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations|
TR Rebbeck, HT Lynch, SL Neuhausen, SA Narod, L Van't Veer, ...
New England Journal of Medicine 346 (21), 1616-1622, 2002
|Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality|
SM Domchek, TM Friebel, CF Singer, DG Evans, HT Lynch, C Isaacs, ...
Jama 304 (9), 967-975, 2010
|Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group|
TR Rebbeck, T Friebel, HT Lynch, SL Neuhausen, L van’t Veer, JE Garber, ...
Journal of Clinical Oncology 22 (6), 1055-1062, 2004
|Low-penetrance susceptibility to breast cancer due to CHEK2* 1100delC in noncarriers of BRCA1 or BRCA2 mutations|
H Meijers-Heijboer, A van den Ouweland, J Klijn, M Wasielewski, ...
Nature genetics 31 (1), 55-59, 2002
|Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS).|
MO Leach, CR Boggis, AK Dixon, DF Easton, RA Eeles, DG Evans, ...
Lancet 365 (9473), 1769, 2005
|Malignant peripheral nerve sheath tumours in neurofibromatosis 1|
DGR Evans, ME Baser, J McGaughran, S Sharif, E Howard, A Moran
Journal of medical genetics 39 (5), 311-314, 2002
|Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002)|
SR Cairns, JH Scholefield, RJ Steele, MG Dunlop, HJW Thomas, ...
Gut 59 (5), 666-689, 2010
|Large-scale genotyping identifies 41 new loci associated with breast cancer risk|
K Michailidou, P Hall, A Gonzalez-Neira, M Ghoussaini, J Dennis, ...
Nature genetics 45 (4), 353-361, 2013
|Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers|
KB Kuchenbaecker, JL Hopper, DR Barnes, KA Phillips, TM Mooij, ...
Jama 317 (23), 2402-2416, 2017
|PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene|
N Rahman, S Seal, D Thompson, P Kelly, A Renwick, A Elliott, S Reid, ...
Nature genetics 39 (2), 165-167, 2007
|The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in†…|
SR Lakhani, MJ Van De Vijver, J Jacquemier, TJ Anderson, PP Osin, ...
Journal of clinical oncology 20 (9), 2310-2318, 2002
|Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial|
J Burn, AM Gerdes, F Macrae, JP Mecklin, G Moeslein, S Olschwang, ...
The Lancet 378 (9809), 2081-2087, 2011
|Guidelines for the diagnosis and management of individuals with neurofibromatosis 1|
RE Ferner, SM Huson, N Thomas, C Moss, H Willshaw, DG Evans, ...
Journal of medical genetics 44 (2), 81-88, 2007
|A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24. 21|
I Tomlinson, E Webb, L Carvajal-Carmona, P Broderick, Z Kemp, S Spain, ...
Nature genetics 39 (8), 984-988, 2007
|Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls|
N Craddock, ME Hurles, N Cardin, RD Pearson, V Plagnol, S Robson, ...
Nature 464 (7289), 713, 2010
|First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial.|
J Cuzick, JF Forbes, I Sestak, S Cawthorn, H Hamed, K Holli, A Howell, ...
The Lancet 360, 817-824, 2002
|Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas|
C Palles, JB Cazier, KM Howarth, E Domingo, AM Jones, P Broderick, ...
Nature Genetics, 2012
|Oral contraceptives and the risk of hereditary ovarian cancer|
SA Narod, H Risch, R Moslehi, A DÝrum, S Neuhausen, H Olsson, ...
New England Journal of Medicine 339 (7), 424-428, 1998